Israeli Heart Valve Company Mvalve Raises $15M From Boston Scientific

July 7, 2014 | According to a “Globes” report, Israeli heart valve company Mvalve raised $15 million from Boston Scientific, and international medical device developer, manufacturer and marketer. Mvalve is developing a solution for leaks in the mitral heart valve and in order to complete its product, received a $15 million loan from BSC International Holdings, a member of the Boston Scientific group. Sources reported to “Globes” that BSC obtained an option to acquire Mvalve for up to $200 million. Mvalve was founded in 2012 by Maurice Buchbinder, the inventor of the technology, and CEO Assif Stoffman.